No abstract available.
Tinnitus*

Aural fullness is common in patients that visit otolaryngology clinics. It is necessary to examine their detailed medical history, have a physical examination and include additional appropriate studies in order to make an accurate diagnosis for patients who complain about aural fullness. Physicians should have extensive knowledge about diseases which can cause aural fullness. In this paper, the author will introduce an appropriate approach to aural fullness and review typical diseases associated with aural fullness.
Humans ; Otolaryngology ; Physical Examination

No abstract available.
Granular Cell Tumor* ; Tongue*

No abstract available.

No abstract available.
Granular Cell Tumor* ; Larynx*

No abstract available.
Otitis Media* ; Otitis* ; Specimen Handling*

BACKGROUND: B cell subset has been divided into B-1 cells and B-2 cells. B-1 cells are found most prominently in the peritoneal cavity, as well as constituting a small proportion of splenic B cells and they are larger and less dense than B-2 cells in morphology. This study was designed to compare the differences in their proliferation and differentiation between B-1 and B-2 cell. METHODS: We obtained sorted B-1 cells from peritoneal fluid and B-2 cells from spleens of mice. Secreted IgM was measured by enzyme-linked immunosorbent assay. Entering of S phase in response to LPS-stimuli was measured by proliferative assay. Cell cycle analysis by propidium iodide was performed. p21 expression was assessed by real time PCR. RESULTS: Cell proliferation and cell cycle progression in B-1 and B-2 cells, which did not occur in the absence of LPS, required LPS stimulation. After LPS stimulation, B-1 and B-2 cells were shifted to S and G2/M phases. p21 expression by resting B-1 cells was higher than that of resting B-2 cells. CONCLUSION: B-1 cells differ from conventional B-2 cells in proliferation, differentiation and cell cycle.
Allergy and Immunology ; Animals ; Ascitic Fluid ; B-Lymphocytes ; Cell Cycle ; Cell Proliferation ; Enzyme-Linked Immunosorbent Assay ; Immunoglobulin M ; Mice ; Peritoneal Cavity ; Propidium ; Real-Time Polymerase Chain Reaction ; S Phase ; Spleen

BACKGROUND: B cell subset has been divided into B-1 cells and B-2 cells. B-1 cells are found most prominently in the peritoneal cavity, as well as constituting a small proportion of splenic B cells and they are larger and less dense than B-2 cells in morphology. This study was designed to compare the differences in their proliferation and differentiation between B-1 and B-2 cell. METHODS: We obtained sorted B-1 cells from peritoneal fluid and B-2 cells from spleens of mice. Secreted IgM was measured by enzyme-linked immunosorbent assay. Entering of S phase in response to LPS-stimuli was measured by proliferative assay. Cell cycle analysis by propidium iodide was performed. p21 expression was assessed by real time PCR. RESULTS: Cell proliferation and cell cycle progression in B-1 and B-2 cells, which did not occur in the absence of LPS, required LPS stimulation. After LPS stimulation, B-1 and B-2 cells were shifted to S and G2/M phases. p21 expression by resting B-1 cells was higher than that of resting B-2 cells. CONCLUSION: B-1 cells differ from conventional B-2 cells in proliferation, differentiation and cell cycle.
Allergy and Immunology ; Animals ; Ascitic Fluid ; B-Lymphocytes ; Cell Cycle ; Cell Proliferation ; Enzyme-Linked Immunosorbent Assay ; Immunoglobulin M ; Mice ; Peritoneal Cavity ; Propidium ; Real-Time Polymerase Chain Reaction ; S Phase ; Spleen

Aging is initiated based on genetic and environmental factors that operate from the time of birth of organisms. Aging induces physiological phenomena such as reduction of cell counts, deterioration of tissue proteins, tissue atrophy, a decrease of the metabolic rate, reduction of body fluids, and calcium metabolism abnormalities, with final progression onto pathological aging. Despite the efforts from many researchers, the progression and the mechanisms of aging are not clearly understood yet. Therefore, the authors would like to introduce several theories which have gained attentions among the published theories up to date; genetic program theory, wear-and-tear theory, telomere theory, endocrine theory, DNA damage hypothesis, error catastrophe theory, the rate of living theory, mitochondrial theory, and free radical theory. Although there have been many studies that have tried to prevent aging and prolong life, here we introduce a couple of theories which have been proven more or less; food, exercise, and diet restriction.
Aging ; Atrophy ; Attention ; Body Fluids ; Calcium ; Cell Count ; Diet ; DNA Damage ; Parturition ; Physiological Phenomena ; Proteins ; Telomere

OBJECTIVE: To evaluated whether clusterin over-expression is significantly correlated with paclitaxel resistance in ovarian cancer cell lines. METHODS: Clusterin was validated by performing expression profiling analysis and subsequently, the correlation between clusterin mRNA expression levels and the IC50 of paclitaxel was tested. Transfection of clusterin was performed on SKOV3, which expressed paclitaxel-sensitivity and low level of clusterin, and transfection of clusterin siRNA on PEOH, which expressed paclitaxel-resistance and high level of clusterin, to evaluate their effect on chemo-sensitivity, apoptosis, and cell cycle by XTT assay, cell death ELISA, and flow cytometry, respectively. RESULTS: Clusterin mRNA and protein expression levels were significantly correlated with paclitaxel resistance (P<0.001). Transfection of cluterin on SKOV3 significantly decreased apoptosis and increased paclitaxel resistance. And transfection of clusterin siRNA on PEOH significantly increased paclitaxel-sensitivity (P<0.05), and shifted cells from S to G2/M phase of the cell cycle after paclitaxel treatment. CONCLUSION: These findings suggested that clusterin overexpression confers paclitaxel-resistance by the modulation of the apoptotic pathway and cell cycle progression in ovarian cancer cells.
Apoptosis ; Cell Cycle ; Cell Death ; Cell Line ; Clusterin* ; Enzyme-Linked Immunosorbent Assay ; Flow Cytometry ; Inhibitory Concentration 50 ; Ovarian Neoplasms* ; Paclitaxel* ; RNA, Messenger ; RNA, Small Interfering ; Transfection